Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 5, 2010, Pages 411-413

  Hu, Yingchuan ^a   Yang, Qi ^a   McMahon, Loralee A ^a   Wang, Hanlin L ^b   Xu, Haodong ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

D2 40; malignant mesothelioma; pleomorphic carcinoma; pleural neoplasm; podoplanin; solitary fibrous tumor; synovial sarcoma

Indexed keywords

MONOCLONAL ANTIBODY D2-40; TUMOR MARKER;

ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG TUMOR; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; PLEURA TUMOR; PRIORITY JOURNAL; SOLITARY FIBROUS TUMOR; SYNOVIAL SARCOMA;

ANTIBODIES, MONOCLONAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; PLEURAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SARCOMA, SYNOVIAL; SOLITARY FIBROUS TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957589984     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181da8387     Document Type: Article

References (21)

1. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002; 15: 434-440.
2. Padgett DM, Cathro HP, Wick M.R., et al. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am J Surg Pathol. 2008; 32: 123-127.
3. Deniz H, Kibar Y, Guldur M.E., et al. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocar-cinoma and benign mesothelial proliferations? Pathol Res Pract. 2009; 205: 749-752.
4. Chu AY, Litzky LA, Pasha T.L., et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol. 2005; 18: 105-110.
5. Saad RS, Lindner JL, Lin X, et al. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Diagn Cytopathol. 2006; 34: 801-806.
6. Muller AM, Franke FE, Muller KM D2-40: a reliable marker in the diagnosis of pleural mesothelioma. Pathobiology. 2006; 73: 50-54.
7. Hinterberger M, Reineke T, Storz M., et al. D2-40 and calretinin-a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol. 2007; 20: 248-255.
8. Takeshima Y, Amatya VJ, Kushitani K, et al. Value of immuno- histochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology. 2009; 54: 667-676.
9. Naito Y, Ishii G, Kawai O., et al. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen. Pathol International. 2007; 57: 618-621.
10. Mentrikoski MJ, Ma L, Pryor J.G., et al. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. Mod Pathol. 2009; 22: 1582-1587.
11. Ordonez NG. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol. 2005; 36: 372-380.
12. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer. 1999; 80: 569-578.
13. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005; 46: 396-402.
14. Tomita T. D2-40 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Pancreas. 2009; 38: 339-340.
15. Nofech-Mozes S., Khalifa MA, Ismiil N, et al. Immunophenotyping of serous carcinoma of the female genital tract. Mod Pathol. 2008; 21: 1147-1155.
16. Kalof AN, Cooper K. D2-40 immunohistochemistry - so far! Adv Anat Pathol. 2009; 16: 62-64.
17. Xie Q, Chen L, Fu K., et al. Podoplanin (d2-40): a new immunohisto-chemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int J Clin Exp Pathol. 2008; 1: 276-284.
18. Marsee DK, Pinkus GS, Hornick JL Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol. 2009; 17: 102-107.
19. Kaddu S, Leinweber B. Podoplanin expression in fibrous histio-cytomas and cellular neurothekeomas. Am J Dermatopathol. 2009; 31: 137-139.
20. Kuroda N, Tanida N, Oonishi K., et al. Significance of D2-40 expression in the diagnosis of gastrointestinal stromal tumor. Med Mol Morphol. 2008; 41: 109-112.
21. Hu Y, Mahar TJ, Hicks D.G., et al. Malignant solitary fibrous tumor: report of 3 cases with unusual features. Appl Immunohistochem Mol Morphol. 2009; 17: 451-457.